-
ALKERMES, INC. et al v. TEVA PHARMACEUTICAL INDUSTRIES USA,INC DC
- 2:20-cv-12470
- D.N.J.
- Judge: Madeline Cox Arleo +1
- Filed: 09/09/2020
- Closed: 08/30/2023
- Latest Docket Entry: 09/15/2023
- PACER
- Docket updated daily
1
Plaintiff
2
Defendants
1
Accused
Product
1
Patent-in-Suit
1,086
Days in
Litigation
-
ALKERMES, INC. et al v. TEVA PHARMACEUTICAL INDUSTRIES USA,INC DC
- 2:20-cv-12470
- D.N.J.
- Judge: Madeline Cox Arleo +1
- Filed: 09/09/2020
- Closed: 08/30/2023
- Latest Docket Entry: 09/15/2023
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Teva Pharmaceuticals USA, Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic version of VIVITROL® (naltrexone) extended-release intramuscular injectable suspension 380 mg/vial | US 7,919,499 B2 | All Asserted Claims |
Infringement
Entry 260
|